PeptideDB

Monoethyl fumarate 2459-05-4

Monoethyl fumarate 2459-05-4

CAS No.: 2459-05-4

Monoethyl fumarate is the monoethyl ester form of fumaric acid. Monoethyl fumarate is an effective preservative and poly
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Monoethyl fumarate is the monoethyl ester form of fumaric acid. Monoethyl fumarate is an effective preservative and polymerization agent for polymer materials.

Physicochemical Properties


Molecular Formula C6H8O4
Molecular Weight 144.13
Exact Mass 144.042
CAS # 2459-05-4
Related CAS # 55141-86-1 (hydrochloride salt);62008-21-3 (zinc salt);62008-22-4 (calcium salt);76260-93-0 (lithium salt)
PubChem CID 5358902
Appearance White to off-white solid powder
Density 1.2±0.1 g/cm3
Boiling Point 147 ºC (16 mmHg)
Melting Point 64-69 ºC
Flash Point 109.6±16.1 °C
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.469
LogP 0.29
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 4
Heavy Atom Count 10
Complexity 159
Defined Atom Stereocenter Count 0
SMILES

O(C(/C(/[H])=C(\[H])/C(=O)O[H])=O)C([H])([H])C([H])([H])[H]

InChi Key XLYMOEINVGRTEX-ONEGZZNKSA-N
InChi Code

InChI=1S/C6H8O4/c1-2-10-6(9)4-3-5(7)8/h3-4H,2H2,1H3,(H,7,8)/b4-3+
Chemical Name

(E)-4-ethoxy-4-oxobut-2-enoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References [1]. Ausama Atwan, et al. Oral Fumaric Acid Esters for Psoriasis. Cochrane Database Syst Rev. 2015 Aug 10;2015(8):CD010497.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (693.82 mM)
H2O: 25 mg/mL (173.45 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (17.35 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (17.35 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (17.35 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 6.9382 mL 34.6909 mL 69.3818 mL
5 mM 1.3876 mL 6.9382 mL 13.8764 mL
10 mM 0.6938 mL 3.4691 mL 6.9382 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.